Quantitative analysis of aromatase mRNA expression derived from various promoters (I.4, I.3, PII and I.7) and its association with expression of TNF-α, IL-6 and COX-2 mRNAs in human breast cancer

被引:74
作者
Irahara, N [1 ]
Miyoshi, Y [1 ]
Taguchi, T [1 ]
Tamaki, Y [1 ]
Noguchi, S [1 ]
机构
[1] Osaka Univ, Sch Med, Dept Surg Oncol, Suita, Osaka 5650871, Japan
关键词
aromatase; promoter; TNF-alpha; IL-6; COX-2; breast cancer;
D O I
10.1002/ijc.21562
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of the present study was to study the aromatase mRNA expression as well as promoter usage (1.4, 1.3, PII and 1.7) in axillary adipose tissue (AA), mammary adipose tissue (MA), breast tumor tissue (BT) and adjacent normal breast tissue (NB), and to study the relationship between aromatase mRNA expression and tumor necrosis factor (TNF)-alpha, interleukin (IL)-6 and cyclooxygenase (COX)-2 mRNA expression. BT (it 108), NB (n = 54), AA (n = 41) and MA (n = 34) from patients with breast cancer were subjected to real-time PCR assays for the mRNA levels of aroniatase, TNF-alpha, IL-6 and COX-2. We also studied the usage of promoters 1.4, 1.3, PII and the recently reported endothelial promoter 1.7. Total aroniatase mRNA levels were significantly up-regulated in BT as compared with NB, AA and MA. Proportion of promoter 1.4-specific transcripts against the total transcripts was significantly decreased and that of promoter 1.3- and 1.7-specific transcripts was significantly increased in BT than NB, AA and MA. However, the amount 4 transcripts from all the 4 promoters was significantly up-regulated in BT than NB, AA and MA. Estrogen receptor-alpha (ER-alpha) positive tumors showed a higher percentage of promoter 1.7 usage than ER-alpha negative tumors with a marginal significance (p = 0.05), and tumor with high microvessel counts tended (p = 0.06) to show a higher percentage of promoter 1.7 usage than those with low microvessel counts. There was a significant association between aroinatase mRNA levels and TNF-alpha, IL-6 or COX-2 mRNA levels in BT, AA and MA but not in NB. These results suggest that enhanced transcription of promoters 1.4, 1.3, PII and 1.7 explains the up-regulation of aroinatase mRNA levels in BT. It has also been suggested that angiogenesis might stimulate the growth of ER-a positive tumors through the enhanced transcription of aromatase from promoter I. 7 in endo thelial cells in BT, and that TNF-alpha, IL-6 and COX-2 might be implicated in the up-regulation of aroinatase mRNA in BT, AA and MA but not in NB. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:1915 / 1921
页数:7
相关论文
共 26 条
  • [1] Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients
    Agarwal, VR
    Bulun, SE
    Leitch, M
    Rohrich, R
    Simpson, ER
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (11) : 3843 - 3849
  • [2] Aromatase and COX-2 expression in human breast cancers
    Brodie, AMH
    Lu, Q
    Long, BJ
    Fulton, A
    Chen, T
    Macpherson, N
    DeJong, PC
    Blankenstein, MA
    Nortier, JWR
    Slee, PHTJ
    van de Ven, J
    van Gorp, JMHH
    Elbers, JRJ
    Schipper, MEI
    Blijham, GH
    Thijssen, JH
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2001, 79 (1-5) : 41 - 47
  • [3] Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens
    Brueggemeier, RW
    Quinn, AL
    Parrett, ML
    Joarder, FS
    Harris, RE
    Robertson, FM
    [J]. CANCER LETTERS, 1999, 140 (1-2) : 27 - 35
  • [4] Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast
    Bulun, SE
    Sharda, G
    Rink, J
    Sharma, S
    Simpson, ER
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) : 1273 - 1277
  • [5] Importance of focal aromatase activity in hormone-dependent breast cancer: a review
    de Jong, PC
    Blankenstein, MA
    van de Ven, J
    Nortier, JWR
    Blijham, GH
    Thijssen, JHH
    [J]. BREAST, 2001, 10 (02) : 91 - 99
  • [6] Quantitative analysis of estrogen receptor-α and -β messenger RNA expression in normal and malignant thyroid tissues by real-time polymerase chain reaction
    Egawa, C
    Miyoshi, Y
    Iwao, K
    Shiba, E
    Noguchi, S
    [J]. ONCOLOGY, 2001, 61 (04) : 293 - 298
  • [7] Foekens JA, 2001, CANCER RES, V61, P5407
  • [8] Real-time reverse transcription PCR assay of CYP19 expression:: application to a well-defined series of post-menopausal breast carcinomas
    Girault, I
    Lerebours, F
    Tozlu, S
    Tubiana-Hulin, M
    Lidereau, R
    Biche, I
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2002, 82 (4-5) : 323 - 332
  • [9] Hansen S, 2000, BRIT J CANCER, V82, P339
  • [10] TISSUE-SPECIFIC EXPRESSION OF THE HUMAN AROMATASE CYTOCHROME-P-450 GENE BY ALTERNATIVE USE OF MULTIPLE EXONS-1 AND PROMOTERS, AND SWITCHING OF TISSUE-SPECIFIC EXONS-1 IN CARCINOGENESIS
    HARADA, N
    UTSUMI, T
    TAKAGI, Y
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (23) : 11312 - 11316